Ueno Satoshi, Katakura Shin, Okimura Tadashi, Kato Keiichi
Kato Ladies Clinic, 7-20-3 Nishi-shinjuku, Shinjuku, Tokyo, 160-0023, Japan.
Reprod Sci. 2025 Apr 3. doi: 10.1007/s43032-025-01842-6.
Although essential to confirm the clinical utility of direct cleavage embryos, the timing of rapid cleavage (RpiC) has not been specifically defined. This study aimed to explore the differences in embryonic and clinical outcomes based on varying timing parameters of direct cleavage during first cytokinesis, using time to reach the three-cell stage (t3) minus time to reach the two-cell stage (t2). We analyzed 19,796 fertilized embryos (in 6,907 patients) from a single center between September 2019 and December 2020. The embryos were cultured using EmbryoScope, and t2 and t3 were recorded. Trichotomous mitosis (TM) was defined as t3 - t2 = 0 h, and RpiC events were divided into four groups, as follows: 0 h < t3 - t2 < 1 h (RpiC-1), 1 h ≤ t3 - t2 < 3 h (RpiC-3), 3 h ≤ t3 - t2 < 5 h (RpiC-5), and 5 h ≤ t3 - t2 < 7 h (RpiC-7). Additionally, 7 h ≤ t3 - t2 < 14 h was defined as normal cleavage. After single-cleavage embryo transfer, the live-birth, TM, and RpiC-1 rates were significantly lower than those in other groups. Similarly, when blastocysts were utilized, the TM and RpiC-1 rates were significantly lower than those in other groups. This study suggests that embryos with TM or RpiC-1 (t3 - t2 < 1 h) should be cultured to the blastocyst stage to prevent unnecessary embryo transfers, although outcomes may vary in different scenarios, i.e., by institution and patient.
尽管对于确认直接分裂胚胎的临床效用至关重要,但快速分裂的时间(RpiC)尚未有明确的定义。本研究旨在探讨基于第一次胞质分裂期间直接分裂的不同时间参数,以到达三细胞阶段的时间(t3)减去到达二细胞阶段的时间(t2),胚胎和临床结局的差异。我们分析了2019年9月至2020年12月期间来自单一中心的19796个受精胚胎(6907例患者)。胚胎使用EmbryoScope进行培养,并记录t2和t3。三分体有丝分裂(TM)定义为t3 - t2 = 0小时,RpiC事件分为四组,如下:0小时<t3 - t2<1小时(RpiC-1),1小时≤t3 - t2<3小时(RpiC-3),3小时≤t3 - t2<5小时(RpiC-5),以及5小时≤t3 - t2<7小时(RpiC-7)。此外,7小时≤t3 - t2<14小时定义为正常分裂。单分裂胚胎移植后,活产、TM和RpiC-1率显著低于其他组。同样,当使用囊胚时,TM和RpiC-1率也显著低于其他组。本研究表明,具有TM或RpiC-1(t3 - t2<1小时)的胚胎应培养至囊胚阶段,以防止不必要的胚胎移植,尽管不同情况下(即不同机构和患者)结局可能有所不同。